Table 4.
Variable | Test for recurrence-free survival | Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|---|
Hazard ratio | 95% CI | P | Hazard ratio | 95% CI | P | ||
Age | >60 versus ≤60 | 0.657 | 0.262–1.647 | 0.371 | |||
Sex | Male versus female | 0.463 | 0.187–1.149 | 0.097 | |||
Tumour location | Rectum versus colon | 0.448 | 0.176–1.142 | 0.093 | |||
Tumour size | >4.25 versus ≤4.25 | 2.336 | 0.885–6.172 | 0.087 | |||
T Stage | 3/4 versus 1/2 | 2.018 | 0.987–4.123 | 0.054 | |||
Lymph node metastasis | Yes versus No | 1.182 | 0.463–3.021 | 0.727 | |||
Lymphovascular invasion | Yes versus No | 2.396 | 0.842–6.815 | 0.101 | |||
Tumour grade | Poor versus well/Moderate | 3.143 | 1.272–7.767 | 0.013 | 3.837 | 1.501–9.81 | 0.005 |
Adjuvant treatment | Yes versus No | 1.803 | 0.596–5.449 | 0.296 | |||
SUVTumor | >10.65 versus ≤10.65 | 1.613 | 0.601–4.334 | 0.343 | |||
SUVLN | >1.15 versus ≤1.15 | 4.538 | 1.317–15.642 | 0.017 | 10.107 | 2.832–36.064 | <0.0001 |